在通过p38信号传递在小鼠的实验性自身免疫脑膜炎期间,CRTH2对于产生IL-1β的B细胞至关重要
Jiao Liu1, Bei Wang1, Chunyan Wu2
1Department of Pharmacology, Tianjin Key Laboratory of Inflammatory Biology, Center for Cardiovascular Diseases, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, State Key Laboratory of Experimental Hematology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Journal of neuroinflammation
|August 8, 2025
概括
在TH2细胞 (CRTH2) 上表达的化学吸引剂受体同类分子驱动B细胞中的IL-1β产生,这是多发性硬化症 (MS) 等自身免疫性疾病的关键因素. 抑制CRTH2信号改善了实验性自身免疫脑膜炎 (EAE),这表明了治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
- 细胞生物学 细胞生物学
背景情况:
- B细胞与自身免疫性炎症性疾病的发病有关,包括多发性硬化症 (MS).
- 已知表达在TH2细胞 (CRTH2),前列腺素D2受体上的化学吸引剂受体同类分子调解Th2细胞激活,但其在B淋巴细胞中的作用仍未定义.
研究的目的:
- 为了研究CRTH2在B淋巴细胞中的功能.
- 确定CRTH2在实验性自身免疫脑膜炎 (EAE) 病原发生中的作用,这是MS的动物模型.
主要方法:
- 产生了具有B细胞特异性Crth2.2缺失的小鼠.
- 利用流细胞计和单细胞测序来识别B细胞亚群.
- 研究了参与CRTH2-介导IL-1β产生的信号通路.
- 在转基因小鼠和采用B细胞转移后评估了EAE疾病的严重程度.
- 研究了EAE中p38信号抑制的治疗潜力.
主要成果:
- 对于特定的IL-1β生成B细胞子集,CRTH2是必不可少的.
- 在B细胞中缺乏Crth2的小鼠显示IL-1β产生B细胞减少,EAE改善.
- 收养Crth2-缺乏B细胞的转移减轻了EAE的严重程度.
- 产生IL-1β的B细胞子集主要被确定为过渡性2型B细胞.
- 通过p38信号传递,CRTH2促进B细胞中的IL-1β的产生;p38抑制降低了EAE的严重程度.
结论:
- CRTH2在驱动B细胞内IL-1β表达方面发挥着至关重要的作用.
- 这种依赖CRTH2的B细胞的IL-1β产生有助于MS等自身免疫性疾病的发病.
- 针对CRTH2或其下游信号通路,如p38,代表了对自身免疫疾病的潜在治疗策略.
相关概念视频
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K


